C9084

Category

C. Outpatient PPS, temporary

NDC crosswalk

None in the loaded CMS ASP file

CMS HCPCS quarterly update

These sit next to C9084 in the CMS Level II file. All C codes

• C9079Injection, evinacumab-dgnb, 5 mg
• C9080Injection, melphalan flufenamide hydrochloride, 1 mg
• C9081Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
• C9082Injection, dostarlimab-gxly, 100 mg
• C9083Injection, amivantamab-vmjw, 10 mg
• C9085Injection, avalglucosidase alfa-ngpt, 4 mg
• C9086Injection, anifrolumab-fnia, 1 mg
• C9087Injection, cyclophosphamide, (auromedics), 10 mg
• C9088Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
• C9089Bupivacaine, collagen-matrix implant, 1 mg